UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Income Statement [Abstract]
Revenues	$ 1,138,032	$ 96,158	$ 2,161,347	$ 186,951
Operating expenses
General and administrative	261,528	2,963	471,460	8,466
Rent expense	109,508	1,012	199,539	2,512
Management fees	30,000		60,000
Professional fees	112,149	(52,744)	161,736	(52,708)
Salaries and wages	438,842	46,275	875,667	59,127
Depreciation and amortization	134,243	33,108	266,243	65,233
Total operating expenses	1,086,270	30,614	2,034,645	82,630
Operating Income	51,762	65,544	126,702	104,321
Other Income (expense)
Other income	1,045		11,063
Penalty on convertible debt				(9,240)
Loss on advance		(120,000)		(120,000)
Fair value of warrants granted to convertible debt holders				(976,788)
Interest expense	(122,848)	(474,008)	(203,616)	(737,988)
Amortization of debt discount	(211,202)	(847,865)	(464,034)	(1,350,542)
Derivative liability movement	(67,039)	(1,146,864)	130,437	(1,723,619)
Foreign exchange movements	193,368	(101,247)	97,812	(180,738)
Net loss before income taxes	(154,914)	(2,626,438)	(301,636)	(4,994,594)
Income taxes	(24,700)		(42,963)
Net loss	(179,614)	(2,626,438)	(344,599)	(4,994,594)
Net income attributable to non-controlling interest	(14,176)		(23,638)
Net loss allocable to Ethema Health Corporation Stockholders	(193,790)	(2,626,438)	(368,237)	(4,994,594)
Preferred stock dividend	(24,728)	(19,232)	(49,341)	(50,079)
Net loss available to common shareholders of Ethema Health Corporation	(218,518)	(2,645,670)	(417,578)	(5,044,673)
Foreign currency translation adjustment	(72,869)	35,311	(38,352)	64,917
Total comprehensive loss	$ (291,387)	$ (2,610,359)	$ (455,930)	$ (4,979,756)
Loss per share
Basic and diluted	$ (0.00)	$ (0.00)	$ (0.00)	$ (0.00)
Weighted average common shares outstanding
Basic and diluted	3,729,053,805	2,397,374,825	3,680,158,777	2,271,234,382